Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
20 p, 786.4 KB Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America : a cohort study / Trickey, A. (University of Bristol) ; Zhang, L. (University of Bristol) ; Gill, M.J. (University of Calgary) ; Bonnet, F. (Centre Hospitalier Universitaire de Bordeaux) ; Burkholder, G. (University of Alabama at Birmingham) ; Castagna, A. (University vita E Salute) ; Cavassini, M. (Lausanne University Hospital) ; Cichon, P. (Otto-Wagner Hospital) ; Crane, H. (University of Washington) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Grabar, S. (St Antoine Hospital) ; Guest, J. (Emory University) ; Obel, N. (Copenhagen University Hospital) ; Psichogiou, M. (National and Kapodistrian University of Athens) ; Rava, M. (Instituto de Salud Carlos III) ; Reiss, P. (Amsterdam Institute for Global Health and Development) ; Rentsch, C.T. (London School of Hygiene & Tropical Medicine) ; Riera, M. (Fundación Instituto de Investigación Sanitaria Illes Balears) ; Schuettfort, G. (Frankfurt University Hospital) ; Silverberg, M.J. (Kaiser Permanente Northern California) ; Smith, C. (University College London) ; Stecher, M. (German Center for Infection Research) ; Sterling, T.R. (Vanderbilt University School of Medicine) ; Ingle, S.M. (University of Bristol) ; Sabin, C.A. (University College London) ; Sterne, J.A.C. (University of Bristol) ; Universitat Autònoma de Barcelona
Over the past decade, antiretroviral therapy (ART) regimens that include integrase strand inhibitors (INSTIs) have become the most commonly used for people with HIV starting ART. Although trials and observational studies have compared virological failure on INSTI-based with other regimens, few data are available on mortality in people with HIV treated with INSTIs in routine care. [...]
2022 - 10.1016/S2352-3018(22)00046-7
The lancet. HIV, Vol. 9 Núm. 6 (june 2022) , p. e404-e413  
2.
14 p, 1.3 MB Infections in Dupilumab Clinical Trials in Atopic Dermatitis : A Comprehensive Pooled Analysis / Eichenfield, Lawrence (Division of Pediatric and Adolescent Dermatology. Rady Children's Hospital) ; Bieber, T. (Department of Dermatology and Allergy. Christine Kühne-Center for Allergy Research and Education. University of Bonn) ; Beck, Lisa (University of Rochester Medical Center. Department of Dermatology) ; Simpson, E. L. (Oregon Health and Science University. Department of Dermatology) ; Thaçi, Diamant (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; de Bruin-Weller, Marjolein (University Medical Center Utrecht) ; Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ; Silverberg, J. I. (Northwestern University Feinberg School of Medicine) ; Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fölster-Holst, R. (University Hospital Schleswig-Holstein. Dermatology) ; Chen, Z. (Regeneron Pharmaceuticals. Inc.) ; Graham, N. M. H. (Regeneron Pharmaceuticals. Inc.) ; Pirozzi, G. (Sanofi) ; Akinlade, Bolanle (Regeneron Pharmaceuticals. Inc.) ; Yancopoulos, G. D. (Regeneron Pharmaceuticals. Inc.) ; Ardeleanu, Marius (Regeneron Pharmaceuticals. Inc.) ; Universitat Autònoma de Barcelona
Background: Patients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections. Immunomodulators (e. g. , anti-tumor necrosis factors, anti-interleukin [anti-IL]-23, anti-IL-17, Janus kinase inhibitors) increase risk of infections. [...]
2019 - 10.1007/s40257-019-00445-7
American Journal of Clinical Dermatology, Vol. 20 Núm. 3 (january 2019) , p. 443-456  

Vegeu també: autors amb noms similars
1 Silverberg, J. I.
1 Silverberg, J.I.
1 Silverberg, Jonathan I.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.